Acute Lymphobkastic Leukemia Recruiting Phase 4 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0068117 (Acute Lymphobkastic Leukemia)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs